HRS-1738

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-1738, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients [Phase 1, Phase 2]